PGA Tour star Bryson DeChambeau has invested in Proteus Motion, a multi-planar training system that uses magnetic 3D resistance and data-collecting software for advanced functional power training. DeChambeau’s involvement was part of a $3 million seed round that valued Proteus at $40 million.
Proteus Motion has now raised about $9 million in total, including investments from Harris Blitzer Sports & Entertainment, the family office of late NBA commissioner David Stern, Baseball Hall of Famer Dave Winfield and the Hospital for Special Surgery. Proteus, which was initially incorporated as Boston Biomotion and inspired by an original concept from CEO Sam Miller’s father, released its version 2.0 machine this spring. New York Yankees director of player health and performance Eric Cressey is also an advisor and investor.
DeChambeau, the 7th-rated golfer in the world and SportTechie’s honoree as 2020 Outstanding Athlete, invested in Proteus soon after seeing an Instagram ad for the product, as first reported by Sportico.
“The Proteus system has been an amazing tool to see how much power and acceleration I am producing in my rotational motions,” DeChambeau said in a statement. “Proteus allows me to see if I’m getting stronger each week, if I need to work harder and what adjustments I should be making to optimize my training. Proteus Motion has groundbreaking technology that I believe will revolutionize strength training for athletes across all levels of sports.”
